Literature DB >> 14597028

Acute endophthalmitis following intravitreal triamcinolone acetonide injection.

Darius M Moshfeghi1, Peter K Kaiser, Ingrid U Scott, Jonathan E Sears, Matthew Benz, Juan P Sinesterra, Richard S Kaiser, Sophie J Bakri, Raj K Maturi, Jonathan Belmont, Paul M Beer, Timothy G Murray, Hugo Quiroz-Mercado, William F Mieler.   

Abstract

PURPOSE: To report the clinical features, causative organisms, management, and visual acuity outcomes of eight eyes of eight patients who developed acute postoperative endophthalmitis following intravitreal injection of triamcinolone acetonide (IVTA).
DESIGN: Retrospective, multicenter, interventional, case series.
METHODS: A retrospective, interventional, case series of all patients with acute postoperative endophthalmitis following IVTA at seven academic clinical centers between March 2001 and July 2002.
RESULTS: A total of 922 IVTAs were performed. Eight eyes of eight patients with acute postoperative endophthalmitis were identified in the 6 weeks following IVTA for an incidence of 0.87% (95% confidence interval of 0.38% to 1.70%). The median time to presentation was 7.5 days (range, 1-15 days) after IVTA. The most common clinical findings were iritis (n = 8), vitritis (n = 8), hypopyon (n = 8), pain (n = 7), red eye (n = 6), and decreased vision (n = 5). The median presenting visual acuity was 20/1127 (range, 20/60 to light perception). Initial treatment consisted of vitreous tap and injection of antibiotics (n = 6) or pars plana vitrectomy and injection of intravitreal antibiotics (n = 2). Intraocular cultures yielded identification in seven patients. One demonstrated intracellular gram-positive cocci in chains with numerous polymorphonuclear cells on gram stain. The median postinfection vision was 20/400 (range, 20/40 to no light perception). Three patients ended up with no light perception visual acuity, including enucleation (n = 1) and phthisis (n = 1).
CONCLUSIONS: Acute postoperative endophthalmitis following IVTA occurs rapidly and can result in severe loss of vision.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14597028     DOI: 10.1016/s0002-9394(03)00483-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  77 in total

Review 1.  [Ocular side effects and complications of intravitreal triamcinolone acetonide injection].

Authors:  G B Jaissle; P Szurman; K U Bartz-Schmidt
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

2.  Viral retinitis after intravitreal triamcinolone injection in patients with predisposing medical comorbidities.

Authors:  Ankur M Shah; Stephen F Oster; William R Freeman
Journal:  Am J Ophthalmol       Date:  2010-03       Impact factor: 5.258

3.  Vitreous prolapse and IOL dislocation during intravitreal injection of triamcinolone acetonide.

Authors:  Robert F Degenring; Gangolf Sauder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-20       Impact factor: 3.117

4.  Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye.

Authors:  B R Kosobucki; W R Freeman; L Cheng
Journal:  Br J Ophthalmol       Date:  2006-03-10       Impact factor: 4.638

5.  Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).

Authors:  Baruch D Kuppermann; Leandro Cabral Zacharias; M Cristina Kenney
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

6.  Trans-Tenon's retrobulbar injection of triamcinolone acetonide for diffuse diabetic macular edema.

Authors:  Mitsumasa Wada; Nahoko Ogata; Keizo Minamino; Masataka Koriyama; Akiko Higuchi; Miyo Matsumura
Journal:  Jpn J Ophthalmol       Date:  2005 Nov-Dec       Impact factor: 2.447

7.  Efficacy and complications of intravitreal injection of triamcinolone acetonide for refractory cystoid macular edema associated with intraocular inflammation.

Authors:  Zhenyu Dong; Kenichi Namba; Nobuyoshi Kitaichi; Chiho Goda; Mizuki Kitamura; Shigeaki Ohno
Journal:  Jpn J Ophthalmol       Date:  2008-11-11       Impact factor: 2.447

8.  Intraocular inflammation following intravitreal injection of bevacizumab.

Authors:  Sophie J Bakri; Theresa A Larson; Albert O Edwards
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-01-17       Impact factor: 3.117

9.  The Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates.

Authors:  Brian L VanderBeek; Sarah G Bonaffini; Liyuan Ma
Journal:  Ophthalmology       Date:  2015-08-15       Impact factor: 12.079

10.  Study of the Acute Effects of Povidone-Iodine on Conjunctival Bacterial Flora.

Authors:  Jeff H Pettey; Mark D Mifflin; Randall J Olson
Journal:  J Ocul Pharmacol Ther       Date:  2015-08-19       Impact factor: 2.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.